Focus Taiwan
Date: 06/10/2020
By: Chang Ming-hsuan and Chiang Yi-ching

Taipei, June 10 (CNA) Taiwanese researchers who have come up with a Chinese medicine prescription to treat mild cases of COVID-19 are planning on selling the medicine overseas, they said at a press conference on Wednesday.

The prescription includes the dried root of Scutellaria baicalensis, or Chinese skullcap, and Houttuynia cordata, also known as fish mint, and could be available in Europe and the United States as early as July, according to the National Research Institute of Chinese Medicine (NRICM) research team.

The team has signed a non-exclusive license with a manufacturer in Taiwan and is in the process of obtaining a permit to export the medicine, it said.

Led by NRICM Director Su Yi-Chang (蘇奕彰), the team has devised four prescriptions for treating COVID-19 so far, one each aimed at mild, moderate, and severe cases, as well as one that helps those in the recovery stage of the disease.    [FULL  STORY]